STABLE COMPOSITION OF FESOTERODINE
The present invention relates to a stable pharmaceutical composition comprising Fesoterodine or pharmaceutically acceptable salt thereof, amorphous hydrated silicon dioxide and other suitable pharmaceutically acceptable excipients; wherein process for preparation of a stable pharmaceutical compositi...
Saved in:
| Main Authors | , , , , , |
|---|---|
| Format | Patent |
| Language | English French |
| Published |
31.10.2013
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | The present invention relates to a stable pharmaceutical composition comprising Fesoterodine or pharmaceutically acceptable salt thereof, amorphous hydrated silicon dioxide and other suitable pharmaceutically acceptable excipients; wherein process for preparation of a stable pharmaceutical composition comprising step of pre-drying of excipients and the composition is devoid of sugar alcohol. Further, the present invention also provides process for the preparation of said composition.
La présente invention concerne une composition pharmaceutique stable comprenant de la fésotérodine ou son sel pharmaceutiquement acceptable, du dioxyde de silicium hydraté amorphe et d'autres excipients adaptés pharmaceutiquement acceptables. Le procédé de préparation de ladite composition pharmaceutique stable comprend une étape de pré-séchage des excipients, et ladite composition est dépourvue d'alcool de sucre. En outre, la présente invention porte sur un procédé de préparation de ladite composition. |
|---|---|
| AbstractList | The present invention relates to a stable pharmaceutical composition comprising Fesoterodine or pharmaceutically acceptable salt thereof, amorphous hydrated silicon dioxide and other suitable pharmaceutically acceptable excipients; wherein process for preparation of a stable pharmaceutical composition comprising step of pre-drying of excipients and the composition is devoid of sugar alcohol. Further, the present invention also provides process for the preparation of said composition.
La présente invention concerne une composition pharmaceutique stable comprenant de la fésotérodine ou son sel pharmaceutiquement acceptable, du dioxyde de silicium hydraté amorphe et d'autres excipients adaptés pharmaceutiquement acceptables. Le procédé de préparation de ladite composition pharmaceutique stable comprend une étape de pré-séchage des excipients, et ladite composition est dépourvue d'alcool de sucre. En outre, la présente invention porte sur un procédé de préparation de ladite composition. |
| Author | RONAK, RAJENDRABHAI PATEL JAYANTA, KUMAR MANDAL UMESH, SETTY SHASHANK, BABABHAI PATEL VIJAYSINH, VANVIRSINH CHAUHAN NILESH, BHIKHABHAI PATEL |
| Author_xml | – fullname: UMESH, SETTY – fullname: NILESH, BHIKHABHAI PATEL – fullname: JAYANTA, KUMAR MANDAL – fullname: SHASHANK, BABABHAI PATEL – fullname: RONAK, RAJENDRABHAI PATEL – fullname: VIJAYSINH, VANVIRSINH CHAUHAN |
| BookMark | eNrjYmDJy89L5WRQCg5xdPJxVXD29w3wD_YM8fT3U_B3U3BzDfYPcQ3yd_H0c-VhYE1LzClO5YXS3AzKbq4hzh66qQX58anFBYnJqXmpJfHh_kYGhsaGZgaWBpaOhsbEqQIAtvklQA |
| ContentType | Patent |
| DBID | EVB |
| DatabaseName | esp@cenet |
| DatabaseTitleList | |
| Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Chemistry Sciences |
| DocumentTitleAlternate | COMPOSITION STABLE DE FÉSOTÉRODINE |
| ExternalDocumentID | WO2013160909A1 |
| GroupedDBID | EVB |
| ID | FETCH-epo_espacenet_WO2013160909A13 |
| IEDL.DBID | EVB |
| IngestDate | Fri Jul 19 11:44:17 EDT 2024 |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | false |
| Language | English French |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-epo_espacenet_WO2013160909A13 |
| Notes | Application Number: WO2013IN00174 |
| OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20131031&DB=EPODOC&CC=WO&NR=2013160909A1 |
| ParticipantIDs | epo_espacenet_WO2013160909A1 |
| PublicationCentury | 2000 |
| PublicationDate | 20131031 |
| PublicationDateYYYYMMDD | 2013-10-31 |
| PublicationDate_xml | – month: 10 year: 2013 text: 20131031 day: 31 |
| PublicationDecade | 2010 |
| PublicationYear | 2013 |
| RelatedCompanies | ASTRON RESEARCH LIMITED RONAK, RAJENDRABHAI PATEL JAYANTA, KUMAR MANDAL UMESH, SETTY SHASHANK, BABABHAI PATEL VIJAYSINH, VANVIRSINH CHAUHAN NILESH, BHIKHABHAI PATEL |
| RelatedCompanies_xml | – name: NILESH, BHIKHABHAI PATEL – name: VIJAYSINH, VANVIRSINH CHAUHAN – name: SHASHANK, BABABHAI PATEL – name: JAYANTA, KUMAR MANDAL – name: ASTRON RESEARCH LIMITED – name: RONAK, RAJENDRABHAI PATEL – name: UMESH, SETTY |
| Score | 2.9172254 |
| Snippet | The present invention relates to a stable pharmaceutical composition comprising Fesoterodine or pharmaceutically acceptable salt thereof, amorphous hydrated... |
| SourceID | epo |
| SourceType | Open Access Repository |
| SubjectTerms | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
| Title | STABLE COMPOSITION OF FESOTERODINE |
| URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20131031&DB=EPODOC&locale=&CC=WO&NR=2013160909A1 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1dS8Mw8BhT1Dedih9Tikrfii3tSvswZE1TNnFNsVX3NpKuAUHmcBX_vpes0z0tT_mAyyVwuY_cB8CdLGXIXRV-FlTS8mTAraBX-kh4KC-Xoe8Iob0tUn_44j1OepMWfKxjYXSe0B-dHBEpqkR6r_V7vfg3YsXat3J5L95x6vMhKfqx2WjHjqqa5Zhx1KcZixkxCUG9zUyfV2u-HdrhAHWlHSVIq0z79DVScSmLTaaSHMJuhvDm9RG0qnkH9sm69loH9sbNlzd2G-pbHsNNXgyiJ2oQNs5YPlLGJYMlRkJzhkIpi0cpPYHbhBZkaOFm07-zTd_YJmbuKbRR66_OwHCEawtpe7JETLFx35aSz8RMxa663DmH7jZIF9uXL-FADVePcBfa9dd3dYXctRbX-lJ-Afy5eVg |
| link.rule.ids | 230,309,786,891,25594,76904 |
| linkProvider | European Patent Office |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFOebTsXp1KLSt2JLP2wfhqxftNo2xVbd22i6BgSZw1X89710ne5peQo5uHzAL5dfcncBuGUlswqVh5-ZFZM0ZhaSqZcGAg_Py6VlKJQ23haJEbxojxN90oGPdSxMkyf0p0mOiIgqEe91s18v_i-x3Ma3cnlH37Hp88HPR67YsmOF_5qliK498lLiEkd0HORtYvK8khmyJVtj5Eo790gKeaZ979XmcSmLTaPiH8Buivrm9SF0qnkfes7677U-7MXtkzdWW_Qtj-A6y8d25AkOiVOShfxySSC-4HsZwUMpccPEO4Yb38udQMLOpn9zm76RzZGpJ9BF1l-dgqBQVaZM1lipWxqWwpAZK2Z0xmNX1UIZwHCbprPt4ivoBXkcTaMweTqHfS5abchD6NZf39UFWtqaXjYL9AvPc3xD |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=STABLE+COMPOSITION+OF+FESOTERODINE&rft.inventor=UMESH%2C+SETTY&rft.inventor=NILESH%2C+BHIKHABHAI+PATEL&rft.inventor=JAYANTA%2C+KUMAR+MANDAL&rft.inventor=SHASHANK%2C+BABABHAI+PATEL&rft.inventor=RONAK%2C+RAJENDRABHAI+PATEL&rft.inventor=VIJAYSINH%2C+VANVIRSINH+CHAUHAN&rft.date=2013-10-31&rft.externalDBID=A1&rft.externalDocID=WO2013160909A1 |